| Advances in immunotherapy for glioblastoma multiforme AB Mahmoud, R Ajina, S Aref, M Darwish, M Alsayb, M Taher, SA AlSharif, ... Frontiers in Immunology 13, 944452, 2022 | 66 | 2022 |
| T-cell immunity in pancreatic cancer R Ajina, LM Weiner Pancreas 49 (8), 1014-1023, 2020 | 32 | 2020 |
| SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice R Ajina, D Zamalin, A Zuo, M Moussa, M Catalfamo, SA Jablonski, ... Oncoimmunology 8 (5), e1577127, 2019 | 20 | 2019 |
| An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection CW Shuptrine, R Ajina, EJ Fertig, SA Jablonski, H Kim Lyerly, ZC Hartman, ... Cancer Immunology, Immunotherapy 66, 1529-1544, 2017 | 15 | 2017 |
| Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies R Ajina, DJ Zahavi, YW Zhang, LM Weiner Seminars in cancer biology 65, 28-37, 2020 | 14 | 2020 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 13 | 2016 |
| Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance R Ajina, ZX Malchiodi, AA Fitzgerald, A Zuo, S Wang, M Moussa, ... Cancer Immunology Research 9 (4), 386-400, 2021 | 12 | 2021 |
| Functional genomics: paving the way for more successful cancer immunotherapy R Ajina, D Zamalin, LM Weiner Briefings in functional genomics 18 (2), 86-98, 2019 | 11 | 2019 |
| Paediatric Asthma and the Microbiome: A Systematic Review MG Aldriwesh, AM Al-Mutairi, AS Alharbi, HY Aljohani, NA Alzahrani, ... Microorganisms 11 (4), 939, 2023 | 7 | 2023 |
| SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus AA Alkayyal, R Ajina, M Cacciabue, AA Alkayyal, NH Saeedi, ... Frontiers in Immunology 14, 1082191, 2023 | 5 | 2023 |
| Cancer Immunotherapy R Ajina, D Aldeghaither, S Jablonski, LM Weiner Elsevier, 2017 | 3 | 2017 |
| Therapy with BXCL701 (B), a DPP8, DPP9, DPPIV and FAP inhibitor, in combination with anti-PD1 antibody (PD1) in a syngeneic murine pancreatic ductal adenocarcinoma (PDAC) model ¡K S Wang, A Fitzgerald, R Ajina, SA Jablonsk, LM Weiner, J MacDougall, ... Cancer Research 80 (16_Supplement), 6636-6636, 2020 | 1 | 2020 |
| Immune Selection Pressure Contributes to Pancreatic Cancer Immune Evasion R Ajina, A Zuo, S Wang, M Moussa, CJ Cooper, Y Shen, QR Johnson, ... bioRxiv, 2020.06. 15.151274, 2020 | 1 | 2020 |
| Malignant pancreatic cancer cells respond to immune selection pressure to foster immunosuppression R Ajina, A Zuo, M Moussa, SJ Cooper, Y Shen, QR Johnson, JM Parks, ... Cancer Research 79 (13_Supplement), 4584-4584, 2019 | 1 | 2019 |
| Combination therapy with immune checkpoint inhibitor and CCK-receptor blockade increases survival of pancreatic cancer JP Smith, S Wang, A Reham, SA Jablonski, LM Weiner Cancer Research 76 (14_Supplement), 4023-4023, 2016 | 1 | 2016 |
| Repurposing the oncolytic virus VSV∆ 51M as a COVID-19 vaccine AA Alkayyal, MM Darwish, R Ajina, SY Alabbas, MA Alotaibi, ... Frontiers in Bioengineering and Biotechnology 11, 1150892, 2023 | | 2023 |
| P-288 Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia R Ajina, A Alhareeri, W Philip, N Alsekait, N Alarifi, H Alismail, ... Annals of Oncology 34, S117, 2023 | | 2023 |
| Outcomes of molecular tumor board recommendations for cancer patients with progression on standard of care therapies in Saudi Arabia K Alshammari, F Sabatin, M Hazar-Rethinam, F Alotaibi, R Ajina, ... Cancer Research 83 (7_Supplement), 938-938, 2023 | | 2023 |
| Repurposing the oncolytic virus VSV∆ 51M as a COVID-19 vaccine J Li, M Jabir, TM Alain, AA Alkayyal, AB Mahmoud, AA Alkayyal, ... | | 2023 |
| Repurposing the oncolytic virus VSV£G51M as a COVID-19 vaccine J Li, M Jabir, TM Alain, AA Alkayyal, AB Mahmoud, AA Alkayyal, ... | | 2023 |
